الملخص
بيانات النشر
- المعرّف الرقمي
- 10.18295/squmj.8.2024.050
- المجلة
- مجلة جامعة السلطان قابوس الطبية, 24(3), 418-419
- الناشر
- جامعة السلطان قابوس
- وصول مفتوح
- وصول مفتوح ذهبي
- الترخيص
- CC BY-ND 4.0
اقتبس هذه المقالة
APA 7
Raza, H., Bhutta, M. E., & Siddique, M. H. (2025). Re: Efficacy and Safety of Vildagliptin and Remogliflozin as Add-on Therapy to Metformin in Patients of Type 2 Diabetes Mellitus. Sultan Qaboos University Medical Journal, 24(3), 418-419. https://doi.org/10.18295/squmj.8.2024.050
MLA 9
Raza, Hunain, et al. "Re: Efficacy and Safety of Vildagliptin and Remogliflozin as Add-on Therapy to Metformin in Patients of Type 2 Diabetes Mellitus." Sultan Qaboos University Medical Journal, vol. 24, no. 3, 2025, pp. 418-419. https://doi.org/10.18295/squmj.8.2024.050.
شيكاغو (المؤلف–التاريخ)
Raza, Hunain, Muhammad E. Bhutta, and Muhammad H. Siddique. 2025. "Re: Efficacy and Safety of Vildagliptin and Remogliflozin as Add-on Therapy to Metformin in Patients of Type 2 Diabetes Mellitus." Sultan Qaboos University Medical Journal 24 (3): 418-419. https://doi.org/10.18295/squmj.8.2024.050.
هارفارد
Raza, H., Bhutta, M. E. and Siddique, M. H. (2025) 'Re: Efficacy and Safety of Vildagliptin and Remogliflozin as Add-on Therapy to Metformin in Patients of Type 2 Diabetes Mellitus', Sultan Qaboos University Medical Journal, 24(3), pp. 418-419. doi:10.18295/squmj.8.2024.050.
فانكوفر
Raza H, Bhutta ME, Siddique MH. Re: Efficacy and Safety of Vildagliptin and Remogliflozin as Add-on Therapy to Metformin in Patients of Type 2 Diabetes Mellitus. Sultan Qaboos University Medical Journal. 2025;24(3):418-419. doi:10.18295/squmj.8.2024.050
IEEE
H. Raza, M. E. Bhutta, and M. H. Siddique, "Re: Efficacy and Safety of Vildagliptin and Remogliflozin as Add-on Therapy to Metformin in Patients of Type 2 Diabetes Mellitus," Sultan Qaboos University Medical Journal, vol. 24, no. 3, pp. 418-419, 2025, doi: 10.18295/squmj.8.2024.050.